Alnylam Pharmaceuticals (ALNY) Gross Profit (2018 - 2026)
Alnylam Pharmaceuticals (ALNY) posted Gross Profit of $992.69 million for Q2 2026, up 57.2% from $631.66 million a year earlier and up 3.4% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Gross Profit (2018 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gross Profit at Alnylam Pharmaceuticals was $3.83 billion, up 155.4% year-over-year; for FY2025, it was $3.04 billion, up 56.4% from FY2024.
- Annual Gross Profit has increased for seven consecutive years, with a five-year compound annual growth rate of 48.6% (FY2020 to FY2025).
- In prior years, Alnylam Pharmaceuticals' Gross Profit was $1.94 billion in FY2024 (+24.5%), $1.56 billion in FY2023 (+73.9%), $897.24 million in FY2022 (+23.0%) and $729.28 million in FY2021 (+74.2%).
- Quarterly Gross Profit has run from a low of -$40.18 million in Q1 2025 to a high of $1.05 billion in Q3 2025 over five years.
- On a year-over-year basis, Gross Profit increased in five of the last six quarters, with growth averaging 46.6%.
- The strongest year-over-year quarter for Gross Profit in the past five years was Q3 2023, with growth of 194.6%; the weakest was Q3 2024, with a decline of 37.6%.
- According to Business Quant data, Gross Profit for the three prior quarters was $959.66 million (Q1 2026), $829.31 million (Q4 2025) and $1.05 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn |
| 10 | Alnylam Pharmaceuticals | 34.23 Bn | 22.28 Bn | 992.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 992.69 Mn |
| Mar 31, 2026 | 959.66 Mn |
| Dec 31, 2025 | 829.31 Mn |
| Sep 30, 2025 | 1.05 Bn |
| Jun 30, 2025 | 631.66 Mn |
| Dec 31, 2024 | 490.52 Mn |
| Sep 30, 2024 | 418.94 Mn |
| Jun 30, 2024 | 592.55 Mn |
| Mar 31, 2024 | 439.72 Mn |
| Dec 31, 2023 | 367.74 Mn |
| Sep 30, 2023 | 671.06 Mn |
| Jun 30, 2023 | 243.42 Mn |
| Mar 31, 2023 | 277.86 Mn |
| Dec 31, 2022 | 288.86 Mn |
| Sep 30, 2022 | 227.80 Mn |
| Jun 30, 2022 | 190.78 Mn |
| Mar 31, 2022 | 189.80 Mn |
| Dec 31, 2021 | 224.90 Mn |
| Sep 30, 2021 | 159.54 Mn |
| Jun 30, 2021 | 190.30 Mn |
API Access
Alnylam Pharmaceuticals Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();